Investigation of probiotics in multiple sclerosis.
Mult Scler. 2018 Jan;24(1):58-63. doi: 10.1177/1352458517737390.
Mult Scler. 2018.
PMID: 29307299
Clinical Trial.
None of the disease-modifying therapies (DMTs) currently being used for the management of multiple sclerosis (MS) are 100% effective. In addition, side effects associated with the use of these DMTs have limited the practice of combination therapy. ...VSL3 administra …
None of the disease-modifying therapies (DMTs) currently being used for the management of multiple sclerosis (MS) are 100% eff …